Classification of global measles cases in 2013–17 as due to policy or vaccination failure: a retrospective review of global surveillance data Minal K.

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Laith Yakob, Thomas Walker The Lancet Global Health

The epidemic of chronic kidney disease in Central America

Effectiveness of Canada's tuberculosis surveillance strategy in identifying immigrants at risk of developing and transmitting tuberculosis: a population-based.

The commercial determinants of health

Socioeconomic inequality in neonatal mortality in countries of low and middle income: a multicountry analysis Britt McKinnon, MSc, Sam Harper, PhD, Prof.

Rapid response to HPV vaccination crisis in Ireland

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis Wan Ling.

Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study Dr.

Estimating trends in life expectancy in HIV-positive individuals

Active surveillance for rheumatic heart disease in endemic regions: a systematic review and meta-analysis of prevalence among children and adolescents

Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank.

Petros Isaakidis, Shailly Gupta, Leena Menghaney

Early antenatal care visit: a systematic analysis of regional and global levels and trends of coverage from 1990 to 2013 Ann-Beth Moller, MPH, Max Petzold,

Charity begins at home in global health research funding

Effects of the introduction of new vaccines in Guinea-Bissau on vaccine coverage, vaccine timeliness, and child survival: an observational study Dr Ane.

Socioeconomic status and non-communicable disease behavioural risk factors in low- income and lower-middle-income countries: a systematic review Luke.

When less is more: how many doses of PCV are enough?

Sexual health: a post-2015 palimpsest in global health?

Lessons Learned: Role of Influenza Vaccine Production, Distribution, Supply, and Demand—What It Means for the Provider Walter A. Orenstein, MD, William.

State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household.

Veterinary medicine's increasing role in global health

Alcohol and related health issues in China: action needed

Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1·9 million participants

Burden of obstetric fistula: from measurement to action

State of inequality in diphtheria-tetanus-pertussis immunisation coverage in low-income and middle-income countries: a multicountry study of household.

Effective cross-sector collaborations create sustainability

Alternative vector control methods to manage the Zika virus outbreak: more haste, less speed – Authors' reply Laith Yakob, Thomas Walker The Lancet.

Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis

Rebalancing the global battle against tuberculosis

National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis Shannon Lange,

Rubella vaccination: must not be business as usual

Tackling stigma: fundamental to an AIDS-free future

Arnaud Chiolero The Lancet Public Health

An update on Zika virus infection

The epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review and meta-analysis Dr John W Stanifer, MD, Bocheng Jing, BS, Scott.

Socioeconomic differences in mortality in the antiretroviral therapy era in Agincourt, rural South Africa, 2001–13: a population surveillance analysis

What would happen if we stopped vaccination?

Measuring health and economic wellbeing in the Sustainable Development Goals era: development of a poverty-free life expectancy metric and estimates for.

Health consequences of exposure to e-waste: a systematic review

Socioeconomic inequality in neonatal mortality in countries of low and middle income: a multicountry analysis Britt McKinnon, MSc, Sam Harper, PhD, Prof.

Ashton Barnett-Vanes, Tara Kedia, Stella Anyangwe

Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study Nick.

Mortality risks in children aged 5–14 years in low-income and middle-income countries: a systematic empirical analysis Prof Kenneth Hill, PhD, Linnea.

Ashton Barnett-Vanes, Tara Kedia, Stella Anyangwe

Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.

Causes of vision loss worldwide, 1990–2010: a systematic analysis

Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population.

Prevalence of and factors associated with non-partner rape perpetration: findings from the UN Multi-country Cross-sectional Study on Men and Violence.

Tobacco use and second-hand smoke exposure in young adolescents aged 12–15 years: data from 68 low-income and middle-income countries Prof Bo Xi, PhD,

Sufang Guo, Nuzhat Rafique, Danzhen You, Douglas J Noble

Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis Wan Ling.

Low-technology approaches

Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis Dr Louise C Ivers, MBBCh, Isabelle.

Thank you to our diverse (but not diverse enough) reviewers

Global economic consequences of selected surgical diseases: a modelling study Dr Blake C Alkire, MD, Mark G Shrime, MD, Anna J Dare, PhD, Prof Jeffrey.

Kathleen M Neuzil, Karen L Kotloff The Lancet Global Health

Consigned to the margins: a call for global action to challenge intellectual disability stigma Katrina Scior, Aseel Hamid, Richard Hastings, Shirli Werner,

Double burden of tragedy: stillbirth and obstetric fistula

Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review Alexander K Rowe,

Effect of Haemophilus influenzae type b vaccination without a booster dose on invasive H influenzae type b disease, nasopharyngeal carriage, and population.

Jean H Humphrey, Andrew J Prendergast The Lancet Global Health

Reducing the cardiovascular disease burden for people of all ages in the Americas region: analysis of mortality data, 2000–15 Prof Peter Lloyd-Sherlock,

Is the pharmaceutical industry improving with regard to access to essential medicines? Hans V Hogerzeil, Jayasree K Iyer, Lisanne Urlings, Tara Prasad,

Paradoxes of sustainability with consequences for health

Trends in, and projections of, indicators of universal health coverage in Bangladesh, 1995–2030: a Bayesian analysis of population-based household data

Rheumatic heart disease in Africa: the Mosi-o-Tunya call to action

Wolfgang Högler, Craig F Munns The Lancet Global Health

Sickle cell disease: a new era

20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study Claire A Lawson,

Presentation transcript:

Classification of global measles cases in 2013–17 as due to policy or vaccination failure: a retrospective review of global surveillance data Minal K Patel, MD, Prof Walter A Orenstein, MD The Lancet Global Health Volume 7, Issue 3, Pages e313-e320 (March 2019) DOI: 10.1016/S2214-109X(18)30492-3 Copyright © 2019 World Health Organization Terms and Conditions

Figure 1 Selection and classification of measles cases reported to WHO, 2013–17 MCV=measles-containing vaccine. SIA=supplementary immunisation activity. The Lancet Global Health 2019 7, e313-e320DOI: (10.1016/S2214-109X(18)30492-3) Copyright © 2019 World Health Organization Terms and Conditions

Figure 2 Distribution of programmatically preventable and non-preventable measles cases, 2013–17 The Lancet Global Health 2019 7, e313-e320DOI: (10.1016/S2214-109X(18)30492-3) Copyright © 2019 World Health Organization Terms and Conditions

Figure 3 Categorisation of measles cases that were not programmatically preventable*, 2013–17 MCV=measles-containing vaccine. SIA=supplementary immunisation activity. *People with an unknown vaccination status were excluded. The Lancet Global Health 2019 7, e313-e320DOI: (10.1016/S2214-109X(18)30492-3) Copyright © 2019 World Health Organization Terms and Conditions

Figure 4 Global (A) and regional (B) age distribution of measles cases that were programmatically preventable People with measles who were unprotected because of a programmatic failure to receive any vaccination or failure to receive two doses of measles containing vaccine (if eligible for two doses), 2013–17. People with an unknown vaccination status and those who were born before 1980 were excluded. Southeast Asia region reported cases only for 2015–17. The Lancet Global Health 2019 7, e313-e320DOI: (10.1016/S2214-109X(18)30492-3) Copyright © 2019 World Health Organization Terms and Conditions

Figure 5 Distribution of programmatically preventable and non-preventable measles cases in countries that are endemic for measles (A) and those that have interrupted or eliminated measles (B), 2013–17 The Lancet Global Health 2019 7, e313-e320DOI: (10.1016/S2214-109X(18)30492-3) Copyright © 2019 World Health Organization Terms and Conditions

Figure 6 Categorisation of measles cases that were not programmatically preventable in countries that are endemic for measles (A) and those that have interrupted or eliminated measles (B), 2013–17 People with an unknown vaccination status were excluded. MCV=measles-containing vaccine. SIA=supplementary immunisation activity. The Lancet Global Health 2019 7, e313-e320DOI: (10.1016/S2214-109X(18)30492-3) Copyright © 2019 World Health Organization Terms and Conditions